CD44 and laryngeal carcinoma: Compared to CD44-/ALDH1A1- cells, Qi et al. discovered that CD44+/ALDH1A1+ cells isolated from laryngeal carcinoma tissues displayed higher tumor-initiating capacity and resistance to cisplatin [116].